EcoDrugPlus

Ensembl ID : ENSNBRG00000023208
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSNBRG00000008269
Gene Symbol: -
Cross references: -
923 Possible Orthologues:

Ensembl ID : ENSNBRG00000014130
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSNBRG00000001773
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSNBRG00000008518
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSNBRG00000023505
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSNBRG00000023684
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Ensembl ID : ENSNBRG00000008775
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSNBRG00000024335
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSNBRG00000016202
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSNBRG00000002300
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSNBRG00000009188
Gene Symbol: -
Cross references: -
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).